发明名称 EXTENDED RELEASE PREPARATION
摘要 <p>Disclosed is a sustained release preparation which releases a poorly soluble medicinal agent in a pH-independent manner. Also disclosed is a sustained release preparation which is capable of controlling the C max of a medicinal agent to an adequate amount and is thus capable of maintaining the level of the medicinal agent in the blood to a level at which medicinal effects can be expected for a long period of time. Specifically disclosed is a sustained release preparation which is characterized by containing a pharmaceutically acceptable salt of 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(3-pyridylmethylamino)-3(2H)-pyridazinone, and hypromellose. An organic acid is blended in the sustained release preparation in an amount of less than 1% by mass.</p>
申请公布号 EP2535048(A1) 申请公布日期 2012.12.19
申请号 EP20110742316 申请日期 2011.02.10
申请人 TAISHO PHARMACEUTICAL CO., LTD.;NISSAN CHEMICAL INDUSTRIES, LTD. 发明人 HIRASAWA NORIYUKI;KAMIKIDO NOBUYOSHI;TASAKI AKIHIKO;ITO SHUSEI
分类号 A61K31/501;A61K9/20 主分类号 A61K31/501
代理机构 代理人
主权项
地址